Effect of Statin Treatment on Mortality in a Large Cohort of Heart Failure Patients;Efecto del tratamiento con estatinas en la mortalidad de una gran cohorte de pacientes con insuficiencia cardiaca

Revista Espanola de Cardiologia

Volumn 62, Issue 3, 2009, Pages 323-327

  Jordán, Alejandro J ^a,c   Anguita, Manuel P ^b  

^a HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

^b HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^c NONE   (Spain)

Author keywords

Heart failure; Prognosis; Statins

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE; SPIRONOLACTONE;

ADULT; AGED; ANEMIA; ARTICLE; CARDIOVASCULAR RISK; DRUG EFFECT; FEMALE; FOLLOW UP; GROUPS BY AGE; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTOR VARIABLE; PREVALENCE; PROGNOSIS; RISK FACTOR; SEX DIFFERENCE; SPAIN; SURVIVAL; SURVIVAL RATE; SYSTOLIC DYSFUNCTION; THERAPY EFFECT;

AGED; COHORT STUDIES; FEMALE; HEART FAILURE; HEART FUNCTION TESTS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; SPAIN; SURVIVAL ANALYSIS;

EID: 63849191014     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/S0300-8932(09)70379-3     Document Type: Editorial

References (14)

1. B. Levine, J. Kalman, L. Mayer, H.M. Fillit, and M. Packer Elevated circulating levels of tumor necrosis factor in congestive heart failure N Engl J Med 323 1990 236 241
2. E. Kotlyar, J.A. Vita, M.R. Winter, E.H. Awtry, D.A. Siwik, and J.F. Keaney Jr The relationship between aldosterone, oxidative stress and inflammation in chronic, stable human heart failure J Card Fail 12 2006 122 127
3. S. Sola, M.Q. Mir, S. Lerakis, N. Tandon, and B.V. Khan Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure J Am Coll Cardiol 47 2006 332 337
4. M. Anguita El grupo de investigadores del registro BADAPIC Características clínicas, tratamiento y morbimortalidad a corto plazo de pacientes con insuficiencia cardíaca controlados en consultas específicas de insuficiencia cardíaca. Resultados del Registro BADAPIC Rev Esp Cardiol 57 2004 1159 1169
5. F. Navarro-López Guías para el diagnóstico y manejo de la insuficiencia cardíaca y shock cardiogénico. Informe del Grupo de Trabajo de Insuficiencia Cardíaca de la Sociedad Española de Cardiología Rev Esp Cardiol 52 Supl 2 1999 1 54
6. Guidelines for the diagnosis and treatment of chronic heart failure The Task Force for the diagnosis and treatment of chronic heart failure. European Society of Cardiology Eur Heart J 22 2001 1527 1560
7. H. Sahai, and A. Kurshid Statistics in epidemiology. Methods, techniques and applications 1996 CRC Press
8. M. Ulm A simple method to calculate the confidence interval of a standarized mortality ratio Am J Epidemiol 131 1990 373 375
9. T.B. Horwich, W.R. MacLellan, and G.C. Fonarow Statin therapy is associated with improved survival in ischemic and nonischemic heart failure J Am Coll Cardiol 43 2004 642 648
10. D. Mozaffarian, R. Nye, and W.C. Levy Statin therapy is associated with lower mortality among patients with severe heart failure Am J Cardiol 93 2004 1124 1129
11. J.G. Ray, Y. Gong, K. Sykora, and J.V. Tu Statin use and survival outcomes in elderly patients with heart failure Arch Intern Med 165 2005 62 67
12. J.M. Foody, R. Shah, D. Galusha, F.A. Masoudi, E.P. Havranek, and H.M. Krumholz Statins and mortality among elderly patients hospitalized with heart failure Circulation 113 2006 1086 1092
13. J. Kjekshus, E. Apetrel, V. Barrios, M. Böhm, J. Cleland, and J. Cornel Rosuvastatin in older patients with systolic heart failure N Engl J Med 357 2007 2248 2261
14. L. Tavazzi, G. Tognoni, M.G. Franzosi, R. Latini, A.P. Maggioni, and R. Marchioli Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure Eur J Heart Fail 6 2004 635 641